Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Nerium | 1 | 2021 | 18 | 0.91 | Why? |
| Cardenolides | 1 | 2021 | 24 | 0.90 | Why? |
| Plant Extracts | 1 | 2021 | 1514 | 0.39 | Why? |
| Cricetinae | 4 | 2021 | 3344 | 0.22 | Why? |
| Suspensions | 1 | 2020 | 63 | 0.21 | Why? |
| Organisms, Genetically Modified | 1 | 2020 | 59 | 0.20 | Why? |
| Sindbis Virus | 1 | 2018 | 32 | 0.18 | Why? |
| Genetic Fitness | 1 | 2020 | 339 | 0.18 | Why? |
| Myxovirus Resistance Proteins | 1 | 2018 | 77 | 0.18 | Why? |
| Encephalitis Virus, Venezuelan Equine | 1 | 2018 | 71 | 0.18 | Why? |
| DNA, Complementary | 1 | 2020 | 568 | 0.18 | Why? |
| RNA Virus Infections | 1 | 2020 | 231 | 0.17 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.15 | Why? |
| Vaccines, Subunit | 1 | 2021 | 1088 | 0.14 | Why? |
| Containment of Biohazards | 1 | 2021 | 762 | 0.14 | Why? |
| Orthomyxoviridae Infections | 2 | 2020 | 1001 | 0.13 | Why? |
| RNA | 2 | 2020 | 1278 | 0.13 | Why? |
| Vero Cells | 5 | 2021 | 14117 | 0.13 | Why? |
| Phytotherapy | 1 | 2021 | 743 | 0.13 | Why? |
| Furin | 1 | 2021 | 1054 | 0.13 | Why? |
| Adjuvants, Immunologic | 1 | 2021 | 1709 | 0.11 | Why? |
| Virus Replication | 6 | 2021 | 14331 | 0.10 | Why? |
| Animals | 11 | 2021 | 78931 | 0.09 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.09 | Why? |
| Genome, Viral | 5 | 2021 | 13157 | 0.09 | Why? |
| Bayes Theorem | 1 | 2018 | 3237 | 0.09 | Why? |
| Spike Glycoprotein, Coronavirus | 4 | 2021 | 37182 | 0.08 | Why? |
| Aerosols | 1 | 2020 | 5393 | 0.07 | Why? |
| Mice, Transgenic | 2 | 2021 | 2739 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.06 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.06 | Why? |
| Genetic Complementation Test | 1 | 2021 | 59 | 0.06 | Why? |
| Disease Models, Animal | 4 | 2021 | 10998 | 0.06 | Why? |
| Macaca mulatta | 2 | 2021 | 3716 | 0.05 | Why? |
| Oligodeoxyribonucleotides | 1 | 2021 | 206 | 0.05 | Why? |
| Squalene | 1 | 2021 | 196 | 0.05 | Why? |
| Alum Compounds | 1 | 2021 | 210 | 0.05 | Why? |
| Tissue Culture Techniques | 1 | 2020 | 158 | 0.05 | Why? |
| Clone Cells | 1 | 2020 | 312 | 0.05 | Why? |
| Mutant Proteins | 1 | 2021 | 328 | 0.05 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.05 | Why? |
| Clinical Trials, Phase I as Topic | 1 | 2021 | 242 | 0.05 | Why? |
| Mice, 129 Strain | 1 | 2018 | 36 | 0.05 | Why? |
| Genes, Reporter | 1 | 2020 | 472 | 0.05 | Why? |
| West Nile virus | 1 | 2020 | 206 | 0.05 | Why? |
| Mice, Inbred NOD | 1 | 2018 | 134 | 0.04 | Why? |
| Mice, Inbred Strains | 1 | 2018 | 136 | 0.04 | Why? |
| West Nile Fever | 1 | 2020 | 166 | 0.04 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2021 | 801 | 0.04 | Why? |
| Protein Stability | 1 | 2020 | 756 | 0.04 | Why? |
| Alphavirus | 1 | 2018 | 90 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Proteolysis | 1 | 2021 | 751 | 0.04 | Why? |
| Influenza A virus | 2 | 2020 | 2234 | 0.04 | Why? |
| Mice | 3 | 2021 | 21357 | 0.04 | Why? |
| Horses | 1 | 2018 | 474 | 0.04 | Why? |
| Trachea | 1 | 2020 | 894 | 0.04 | Why? |
| Mesocricetus | 1 | 2020 | 1847 | 0.04 | Why? |
| Washington | 1 | 2020 | 1722 | 0.04 | Why? |
| Lung | 2 | 2020 | 31049 | 0.04 | Why? |
| Cell Line | 2 | 2021 | 12040 | 0.04 | Why? |
| A549 Cells | 1 | 2021 | 2066 | 0.03 | Why? |
| Nucleic Acid Conformation | 1 | 2018 | 621 | 0.03 | Why? |
| Haplotypes | 1 | 2018 | 853 | 0.03 | Why? |
| Species Specificity | 1 | 2018 | 1356 | 0.03 | Why? |
| Virulence | 1 | 2021 | 2172 | 0.03 | Why? |
| Nasal Mucosa | 1 | 2020 | 1218 | 0.03 | Why? |
| Virion | 1 | 2020 | 1444 | 0.03 | Why? |
| Viral Tropism | 1 | 2020 | 1329 | 0.03 | Why? |
| Oropharynx | 1 | 2020 | 1581 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Encephalitis | 1 | 2018 | 797 | 0.03 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2021 | 6049 | 0.02 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.02 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Interferons | 1 | 2020 | 2885 | 0.02 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.02 | Why? |
| Lung Diseases | 1 | 2021 | 2361 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
| Female | 3 | 2021 | 380317 | 0.02 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.02 | Why? |
| Humans | 10 | 2021 | 930598 | 0.02 | Why? |
| Aging | 1 | 2020 | 3581 | 0.02 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.02 | Why? |
| Male | 5 | 2021 | 367725 | 0.02 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
Plante's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(103)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(200)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_